Rauscher May Set Up New Office To Monitor, Coordinate RFPs And Grants, Stop Duplication
In Brief: Cooper Says HEW May Stop Taking New Construction grants; Cancer Act Does Not Give Him That Right
DCT’s Experimental Therapeutic Program Outlined to Board
Rauscher Labels With Congress, Says NCI Needs More Money
A.D. Little Gets 42.4 Million Contract Award
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









